Opportunity Overview
Czechia – Antineoplastic and immunomodulating agents – Léčivé přívky s objavní interferonu beta-1a, peginterferonu alfa-2a, peginterferonu beta-1a, ropeginterferonu alfa-2b
Your competitors are watching the same crowded contracts everyone else is. Track live opportunities like this one worldwide, set deadline alerts, and win where they aren’t. Free for 14 days, no card.
Start FreeSolicitation Details
| Issuing agency | Health |
|---|---|
| Country | Czech Republic |
| Category | Health Services |
| Published | March 05, 2026 |
| Procurement stage | Active solicitation |
| Closed | April 07, 2026 |
| Status | Closed — no longer accepting responses |
| Translation | Translated from Hungarian by GlobalGov’s translation pipeline |
| Official source | View original notice |
| Last verified | August 12, 2026 |
Source: Tenders Electronic Daily (TED), © European Union. Notice content reused under Commission Decision 2011/833/EU; editorial content licensed CC BY 4.0. GlobalGov is not affiliated with the European Union.
Browse Similar Open Opportunities in Czech Republic
See every Czech Republic Health Services opportunity your competition is missing. Free for 14 days.
Get real-time alerts, competitive intelligence, and deadline tracking for this and every market worldwide.
Start Free Trial — No Card RequiredFree 14-day trial · no card required
See who is already competing here →Get a free Czech Republic Health Services intelligence report in your inbox
A personalized report on Czech Republic Health Services opportunities, emailed in 5-10 minutes. One per month, no account needed.